Nanocovax
Nanocovax is a Vietnamese COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology JSC.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Nanocovax is a Vietnamese COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology JSC. It is a subunit vaccine (SARS‑CoV‑2 recombinant spike protein with aluminum adjuvant).
Clinical trials
The Vietnamese health ministry has assessed the Nanocovax vaccine produced by Nanogen as the most promising, having been successfully produced on a laboratory scale and provoked immunogenicity during animal testing.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375297502 under CC BY-SA 4.0; modifications have been made.